25 XP   0   0   10

Sigma Pharmaceuticals Ltd
Buy, Hold or Sell?

Let's analyse Sigma Pharmaceuticals Ltd together

PenkeI guess you are interested in Sigma Pharmaceuticals Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Sigma Pharmaceuticals Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Sigma Pharmaceuticals Ltd

I send you an email if I find something interesting about Sigma Pharmaceuticals Ltd.

Quick analysis of Sigma Pharmaceuticals Ltd (30 sec.)










What can you expect buying and holding a share of Sigma Pharmaceuticals Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.03
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
A$0.29
Expected worth in 1 year
A$0.27
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
A$0.01
Return On Investment
0.9%

For what price can you sell your share?

Current Price per Share
A$1.30
Expected price per share
A$1.0475 - A$1.35
How sure are you?
50%

1. Valuation of Sigma Pharmaceuticals Ltd (5 min.)




Live pricePrice per Share (EOD)

A$1.30

Intrinsic Value Per Share

A$-0.28 - A$0.14

Total Value Per Share

A$0.01 - A$0.44

2. Growth of Sigma Pharmaceuticals Ltd (5 min.)




Is Sigma Pharmaceuticals Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$311.6m$318.8m-$7.1m-2.3%

How much money is Sigma Pharmaceuticals Ltd making?

Current yearPrevious yearGrowGrow %
Making money$1.1m-$4.7m$5.9m499.7%
Net Profit Margin0.0%-0.2%--

How much money comes from the company's main activities?

3. Financial Health of Sigma Pharmaceuticals Ltd (5 min.)




4. Comparing to competitors in the Medical Distribution industry (5 min.)




  Industry Rankings (Medical Distribution)  


Richest
#23 / 41

Most Revenue
#11 / 41

Most Profit
#28 / 41

What can you expect buying and holding a share of Sigma Pharmaceuticals Ltd? (5 min.)

Welcome investor! Sigma Pharmaceuticals Ltd's management wants to use your money to grow the business. In return you get a share of Sigma Pharmaceuticals Ltd.

What can you expect buying and holding a share of Sigma Pharmaceuticals Ltd?

First you should know what it really means to hold a share of Sigma Pharmaceuticals Ltd. And how you can make/lose money.

Speculation

The Price per Share of Sigma Pharmaceuticals Ltd is A$1.295. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sigma Pharmaceuticals Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sigma Pharmaceuticals Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.29. Based on the TTM, the Book Value Change Per Share is A$-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sigma Pharmaceuticals Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.000.1%0.000.1%0.00-0.2%0.010.5%0.011.1%
Usd Book Value Change Per Share0.00-0.3%0.00-0.3%-0.01-0.8%0.00-0.2%-0.01-0.4%
Usd Dividend Per Share0.010.5%0.010.5%0.010.6%0.010.7%0.011.0%
Usd Total Gains Per Share0.000.2%0.000.2%0.00-0.2%0.010.4%0.010.6%
Usd Price Per Share0.40-0.40-0.28-0.37-0.46-
Price to Earnings Ratio555.16-555.16--98.42-84.12-54.95-
Price-to-Total Gains Ratio204.02-204.02--126.01--2.62-27.64-
Price to Book Ratio2.10-2.10-1.46-1.85-2.17-
Price-to-Total Gains Ratio204.02-204.02--126.01--2.62-27.64-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.8447285
Number of shares1183
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.01
Gains per Quarter (1183 shares)2.336.78
Gains per Year (1183 shares)9.3227.11
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
130-21-141-1417
260-42883-2844
390-6217124-4371
4121-8326165-5798
5151-10435206-71125
6181-12544248-85152
7211-14653289-99179
8241-16762330-113206
9271-18771372-128233
10302-20880413-142260

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%8.02.00.080.0%20.04.00.083.3%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%1.09.00.010.0%7.017.00.029.2%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%23.00.01.095.8%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%8.02.00.080.0%17.07.00.070.8%

Fundamentals of Sigma Pharmaceuticals Ltd

About Sigma Pharmaceuticals Ltd

Sigma Healthcare Limited, together with its subsidiaries, engages in the wholesale distribution of pharmaceutical goods and medical consumables primarily in Australia. The company operates various aligned pharmacies, including branded pharmacies under the Amcal, Guardian, Discount Drug Stores, and PharmaSave brands. It also provides retail support services to its branded network of pharmacy members; dose administration aid services; technology and data analytics solutions; and third and fourth-party logistics services to pharmaceutical manufacturers and other supplier partners. The company was founded in 1912 and is headquartered in Clayton, Australia.

Fundamental data was last updated by Penke on 2024-03-14 09:41:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Sigma Pharmaceuticals Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Sigma Pharmaceuticals Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Sigma Pharmaceuticals Ltd to the Medical Distribution industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sigma Pharmaceuticals Ltd:

  • The MRQ is 0.0%. The company is not making a profit/loss.
  • The TTM is 0.0%. The company is not making a profit/loss.
Trends
Current periodCompared to+/- 
MRQ0.0%TTM0.0%0.0%
TTM0.0%YOY-0.2%+0.3%
TTM0.0%5Y0.3%-0.3%
5Y0.3%10Y0.9%-0.6%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0%1.9%-1.9%
TTM0.0%2.2%-2.2%
YOY-0.2%2.4%-2.6%
5Y0.3%2.2%-1.9%
10Y0.9%2.1%-1.2%
1.1.2. Return on Assets

Shows how efficient Sigma Pharmaceuticals Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sigma Pharmaceuticals Ltd to the Medical Distribution industry mean.
  • 0.2% Return on Assets means that Sigma Pharmaceuticals Ltd generated $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sigma Pharmaceuticals Ltd:

  • The MRQ is 0.2%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.2%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.2%TTM0.2%0.0%
TTM0.2%YOY-0.6%+0.7%
TTM0.2%5Y1.0%-0.8%
5Y1.0%10Y2.9%-1.9%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2%0.8%-0.6%
TTM0.2%0.9%-0.7%
YOY-0.6%0.8%-1.4%
5Y1.0%0.9%+0.1%
10Y2.9%1.0%+1.9%
1.1.3. Return on Equity

Shows how efficient Sigma Pharmaceuticals Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sigma Pharmaceuticals Ltd to the Medical Distribution industry mean.
  • 0.4% Return on Equity means Sigma Pharmaceuticals Ltd generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sigma Pharmaceuticals Ltd:

  • The MRQ is 0.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.4%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.4%TTM0.4%0.0%
TTM0.4%YOY-1.5%+1.9%
TTM0.4%5Y2.4%-2.0%
5Y2.4%10Y6.0%-3.6%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4%2.1%-1.7%
TTM0.4%2.5%-2.1%
YOY-1.5%2.2%-3.7%
5Y2.4%2.3%+0.1%
10Y6.0%2.4%+3.6%

1.2. Operating Efficiency of Sigma Pharmaceuticals Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Sigma Pharmaceuticals Ltd is operating .

  • Measures how much profit Sigma Pharmaceuticals Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sigma Pharmaceuticals Ltd to the Medical Distribution industry mean.
  • An Operating Margin of -1.9% means the company generated $-0.02  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sigma Pharmaceuticals Ltd:

  • The MRQ is -1.9%. The company is operating very inefficient. -2
  • The TTM is -1.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1.9%TTM-1.9%0.0%
TTM-1.9%YOY-3.2%+1.3%
TTM-1.9%5Y-1.9%+0.0%
5Y-1.9%10Y0.2%-2.1%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.9%3.1%-5.0%
TTM-1.9%2.6%-4.5%
YOY-3.2%3.5%-6.7%
5Y-1.9%3.3%-5.2%
10Y0.2%2.0%-1.8%
1.2.2. Operating Ratio

Measures how efficient Sigma Pharmaceuticals Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • An Operation Ratio of 1.02 means that the operating costs are $1.02 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Sigma Pharmaceuticals Ltd:

  • The MRQ is 1.019. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.019. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.019TTM1.0190.000
TTM1.019YOY1.032-0.013
TTM1.0195Y1.022-0.003
5Y1.02210Y1.004+0.018
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0191.369-0.350
TTM1.0191.369-0.350
YOY1.0321.413-0.381
5Y1.0221.312-0.290
10Y1.0041.210-0.206

1.3. Liquidity of Sigma Pharmaceuticals Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Sigma Pharmaceuticals Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Distribution industry mean).
  • A Current Ratio of 1.44 means the company has $1.44 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Sigma Pharmaceuticals Ltd:

  • The MRQ is 1.437. The company is just able to pay all its short-term debts.
  • The TTM is 1.437. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.437TTM1.4370.000
TTM1.437YOY1.664-0.228
TTM1.4375Y1.447-0.010
5Y1.44710Y1.603-0.156
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4371.366+0.071
TTM1.4371.418+0.019
YOY1.6641.403+0.261
5Y1.4471.408+0.039
10Y1.6031.299+0.304
1.3.2. Quick Ratio

Measures if Sigma Pharmaceuticals Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sigma Pharmaceuticals Ltd to the Medical Distribution industry mean.
  • A Quick Ratio of 0.74 means the company can pay off $0.74 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sigma Pharmaceuticals Ltd:

  • The MRQ is 0.742. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.742. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.742TTM0.7420.000
TTM0.742YOY0.852-0.110
TTM0.7425Y0.787-0.045
5Y0.78710Y0.998-0.211
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7420.758-0.016
TTM0.7420.757-0.015
YOY0.8520.828+0.024
5Y0.7870.814-0.027
10Y0.9980.850+0.148

1.4. Solvency of Sigma Pharmaceuticals Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Sigma Pharmaceuticals Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sigma Pharmaceuticals Ltd to Medical Distribution industry mean.
  • A Debt to Asset Ratio of 0.60 means that Sigma Pharmaceuticals Ltd assets are financed with 60.2% credit (debt) and the remaining percentage (100% - 60.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sigma Pharmaceuticals Ltd:

  • The MRQ is 0.602. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.602. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.602TTM0.6020.000
TTM0.602YOY0.617-0.014
TTM0.6025Y0.608-0.005
5Y0.60810Y0.551+0.057
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6020.617-0.015
TTM0.6020.606-0.004
YOY0.6170.608+0.009
5Y0.6080.610-0.002
10Y0.5510.593-0.042
1.4.2. Debt to Equity Ratio

Measures if Sigma Pharmaceuticals Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sigma Pharmaceuticals Ltd to the Medical Distribution industry mean.
  • A Debt to Equity ratio of 152.1% means that company has $1.52 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sigma Pharmaceuticals Ltd:

  • The MRQ is 1.521. The company is just able to pay all its debts with equity.
  • The TTM is 1.521. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.521TTM1.5210.000
TTM1.521YOY1.615-0.094
TTM1.5215Y1.557-0.036
5Y1.55710Y1.289+0.268
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5211.698-0.177
TTM1.5211.678-0.157
YOY1.6151.752-0.137
5Y1.5571.733-0.176
10Y1.2891.738-0.449

2. Market Valuation of Sigma Pharmaceuticals Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Sigma Pharmaceuticals Ltd generates.

  • Above 15 is considered overpriced but always compare Sigma Pharmaceuticals Ltd to the Medical Distribution industry mean.
  • A PE ratio of 555.16 means the investor is paying $555.16 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sigma Pharmaceuticals Ltd:

  • The EOD is 1,166.909. Based on the earnings, the company is expensive. -2
  • The MRQ is 555.160. Based on the earnings, the company is expensive. -2
  • The TTM is 555.160. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD1,166.909MRQ555.160+611.748
MRQ555.160TTM555.1600.000
TTM555.160YOY-98.422+653.582
TTM555.1605Y84.118+471.042
5Y84.11810Y54.950+29.168
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD1,166.90913.475+1,153.434
MRQ555.16014.623+540.537
TTM555.16018.845+536.315
YOY-98.42218.249-116.671
5Y84.11817.230+66.888
10Y54.95019.682+35.268
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sigma Pharmaceuticals Ltd:

  • The EOD is 533.116. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 253.631. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 253.631. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD533.116MRQ253.631+279.484
MRQ253.631TTM253.6310.000
TTM253.631YOY52.827+200.805
TTM253.6315Y57.664+195.968
5Y57.66410Y84.324-26.660
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD533.1166.313+526.803
MRQ253.6314.510+249.121
TTM253.6317.516+246.115
YOY52.8275.255+47.572
5Y57.6642.484+55.180
10Y84.3241.762+82.562
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Sigma Pharmaceuticals Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • A PB ratio of 2.10 means the investor is paying $2.10 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Sigma Pharmaceuticals Ltd:

  • The EOD is 4.423. Based on the equity, the company is fair priced.
  • The MRQ is 2.104. Based on the equity, the company is underpriced. +1
  • The TTM is 2.104. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD4.423MRQ2.104+2.319
MRQ2.104TTM2.1040.000
TTM2.104YOY1.458+0.647
TTM2.1045Y1.850+0.255
5Y1.85010Y2.172-0.323
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD4.4231.110+3.313
MRQ2.1041.178+0.926
TTM2.1041.224+0.880
YOY1.4581.307+0.151
5Y1.8501.386+0.464
10Y2.1722.166+0.006
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Sigma Pharmaceuticals Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Sigma Pharmaceuticals Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.007-0.0070%-0.016+132%-0.005-32%-0.008+21%
Book Value Per Share--0.2930.2930%0.300-2%0.303-3%0.321-9%
Current Ratio--1.4371.4370%1.664-14%1.447-1%1.603-10%
Debt To Asset Ratio--0.6020.6020%0.617-2%0.608-1%0.551+9%
Debt To Equity Ratio--1.5211.5210%1.615-6%1.557-2%1.289+18%
Dividend Per Share--0.0100.0100%0.012-20%0.013-27%0.021-53%
Eps--0.0010.0010%-0.004+500%0.010-88%0.021-95%
Free Cash Flow Per Share--0.0020.0020%0.008-71%0.000+117%0.016-85%
Free Cash Flow To Equity Per Share---0.069-0.0690%0.087-179%-0.034-51%-0.013-82%
Gross Profit Margin---115.167-115.1670%30.919-472%-14.925-87%-8.677-92%
Intrinsic Value_10Y_max--0.144--------
Intrinsic Value_10Y_min---0.285--------
Intrinsic Value_1Y_max--0.016--------
Intrinsic Value_1Y_min---0.015--------
Intrinsic Value_3Y_max--0.047--------
Intrinsic Value_3Y_min---0.056--------
Intrinsic Value_5Y_max--0.076--------
Intrinsic Value_5Y_min---0.111--------
Market Cap2113271587.840+52%1005395077.4271005395077.4270%712474421.043+41%913520799.130+10%1139926436.270-12%
Net Profit Margin--0.0000.0000%-0.002+525%0.003-85%0.009-95%
Operating Margin---0.019-0.0190%-0.032+70%-0.019+1%0.002-1222%
Operating Ratio--1.0191.0190%1.032-1%1.0220%1.004+1%
Pb Ratio4.423+52%2.1042.1040%1.458+44%1.850+14%2.172-3%
Pe Ratio1166.909+52%555.160555.1600%-98.422+118%84.118+560%54.950+910%
Price Per Share1.295+52%0.6160.6160%0.437+41%0.560+10%0.699-12%
Price To Free Cash Flow Ratio533.116+52%253.631253.6310%52.827+380%57.664+340%84.324+201%
Price To Total Gains Ratio428.829+52%204.017204.0170%-126.012+162%-2.623+101%27.644+638%
Quick Ratio--0.7420.7420%0.852-13%0.787-6%0.998-26%
Return On Assets--0.0020.0020%-0.006+477%0.010-84%0.029-95%
Return On Equity--0.0040.0040%-0.015+490%0.024-84%0.060-94%
Total Gains Per Share--0.0030.0030%-0.003+215%0.009-66%0.013-76%
Usd Book Value--311646761.800311646761.8000%318829889.400-2%322487074.580-3%341234633.190-9%
Usd Book Value Change Per Share---0.004-0.0040%-0.010+132%-0.003-32%-0.005+21%
Usd Book Value Per Share--0.1910.1910%0.195-2%0.198-3%0.209-9%
Usd Dividend Per Share--0.0060.0060%0.008-20%0.009-27%0.013-53%
Usd Eps--0.0010.0010%-0.003+500%0.006-88%0.014-95%
Usd Free Cash Flow--2585717.2002585717.2000%8797570.100-71%-433388.120+117%17394492.720-85%
Usd Free Cash Flow Per Share--0.0020.0020%0.005-71%0.000+117%0.011-85%
Usd Free Cash Flow To Equity Per Share---0.045-0.0450%0.057-179%-0.022-51%-0.008-82%
Usd Market Cap1378487056.748+52%655819209.006655819209.0060%464747064.846+41%595889617.272+10%743574014.379-12%
Usd Price Per Share0.845+52%0.4020.4020%0.285+41%0.365+10%0.456-12%
Usd Profit--1181315.3001181315.3000%-4721999.700+500%8126483.860-85%21352714.350-94%
Usd Revenue--2387574552.0002387574552.0000%2247932777.200+6%2317924567.200+3%2349088786.770+2%
Usd Total Gains Per Share--0.0020.0020%-0.002+215%0.006-66%0.008-76%
 EOD+4 -4MRQTTM+0 -0YOY+19 -175Y+12 -2410Y+6 -30

4.2. Fundamental Score

Let's check the fundamental score of Sigma Pharmaceuticals Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-151,166.909
Price to Book Ratio (EOD)Between0-14.423
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than0-0.019
Quick Ratio (MRQ)Greater than10.742
Current Ratio (MRQ)Greater than11.437
Debt to Asset Ratio (MRQ)Less than10.602
Debt to Equity Ratio (MRQ)Less than11.521
Return on Equity (MRQ)Greater than0.150.004
Return on Assets (MRQ)Greater than0.050.002
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Sigma Pharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5070.893
Ma 20Greater thanMa 501.215
Ma 50Greater thanMa 1001.113
Ma 100Greater thanMa 2000.968
OpenGreater thanClose1.300
Total5/5 (100.0%)



Latest Balance Sheet

Balance Sheet of 2023-01-31. Currency in AUD. All numbers in thousands.

Summary
Total Assets1,201,609
Total Liabilities723,843
Total Stockholder Equity475,918
 As reported
Total Liabilities 723,843
Total Stockholder Equity+ 475,918
Total Assets = 1,201,609

Assets

Total Assets1,201,609
Total Current Assets685,848
Long-term Assets515,761
Total Current Assets
Cash And Cash Equivalents 16,650
Net Receivables 337,450
Inventory 324,851
Other Current Assets 6,897
Total Current Assets  (as reported)685,848
Total Current Assets  (calculated)685,848
+/- 0
Long-term Assets
Property Plant Equipment 290,923
Goodwill 95,221
Long Term Investments 16,077
Intangible Assets 118,243
Other Assets 0
Long-term Assets  (as reported)515,761
Long-term Assets  (calculated)520,464
+/- 4,703

Liabilities & Shareholders' Equity

Total Current Liabilities477,357
Long-term Liabilities246,486
Total Stockholder Equity475,918
Total Current Liabilities
Short-term Debt 12,944
Short Long Term Debt 3,681
Accounts payable 406,012
Other Current Liabilities 57,445
Total Current Liabilities  (as reported)477,357
Total Current Liabilities  (calculated)480,082
+/- 2,725
Long-term Liabilities
Long term Debt Total 214,041
Other Liabilities 4,909
Long-term Liabilities  (as reported)246,486
Long-term Liabilities  (calculated)218,950
+/- 27,536
Total Stockholder Equity
Common Stock1,286,144
Retained Earnings -761,587
Accumulated Other Comprehensive Income 3,043
Other Stockholders Equity -51,682
Total Stockholder Equity (as reported)475,918
Total Stockholder Equity (calculated)475,918
+/-0
Other
Capital Stock1,234,462
Cash and Short Term Investments 16,650
Common Stock Shares Outstanding 1,046,294
Current Deferred Revenue956
Liabilities and Stockholders Equity 1,201,609
Net Debt 210,335
Net Invested Capital 559,599
Net Tangible Assets 357,675
Net Working Capital 208,491
Property Plant and Equipment Gross 364,014
Short Long Term Debt Total 226,985



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-01-312022-01-312021-01-312020-01-312019-01-312018-01-312017-01-312016-01-312015-01-312014-01-312013-01-312012-01-312011-01-312010-01-312009-01-312008-01-312007-01-312006-01-312005-01-312004-01-312003-01-312002-01-312001-01-312000-01-31
> Total Assets 
545,802
609,041
56,455
64,190
81,090
98,952
1,960,846
2,068,608
2,066,902
2,201,464
1,926,046
1,552,998
1,081,403
1,056,171
945,169
1,055,663
1,108,651
1,118,882
1,308,239
1,383,854
1,229,429
1,219,361
1,275,431
1,201,609
1,201,6091,275,4311,219,3611,229,4291,383,8541,308,2391,118,8821,108,6511,055,663945,1691,056,1711,081,4031,552,9981,926,0462,201,4642,066,9022,068,6081,960,84698,95281,09064,19056,455609,041545,802
   > Total Current Assets 
0
0
52,508
59,474
74,431
88,108
575,514
631,148
631,929
643,998
715,876
1,452,391
941,561
951,388
855,998
879,872
929,368
918,725
1,033,418
1,004,209
735,945
702,196
761,635
685,848
685,848761,635702,196735,9451,004,2091,033,418918,725929,368879,872855,998951,388941,5611,452,391715,876643,998631,929631,148575,51488,10874,43159,47452,50800
       Cash And Cash Equivalents 
22,765
10,762
3,164
2,329
7,634
721
36,195
49,802
47,031
49,986
14,418
556,904
148,601
112,692
67,468
34,284
17,407
24,403
82,249
72,610
104,232
16,128
31,145
16,650
16,65031,14516,128104,23272,61082,24924,40317,40734,28467,468112,692148,601556,90414,41849,98647,03149,80236,1957217,6342,3293,16410,76222,765
       Short-term Investments 
0
0
0
0
0
0
0
2,127
3,439
0
55,448
666
0
0
0
0
0
0
0
0
0
0
14
0
014000000000066655,44803,4392,1270000000
       Net Receivables 
174,047
193,236
30,134
32,592
48,999
61,858
256,206
210,982
229,250
258,496
346,002
648,799
576,056
566,219
557,401
589,957
618,248
566,895
577,870
577,367
301,531
327,304
358,749
337,450
337,450358,749327,304301,531577,367577,870566,895618,248589,957557,401566,219576,056648,799346,002258,496229,250210,982256,20661,85848,99932,59230,134193,236174,047
       Other Current Assets 
4,561
5,672
289
283
406
372
9,405
8,132
6,582
10,112
11,538
21,162
2,687
17,467
8,737
4,246
5,087
5,427
19,318
10,960
14,689
9,626
50,101
6,897
6,89750,1019,62614,68910,96019,3185,4275,0874,2468,73717,4672,68721,16211,53810,1126,5828,1329,4053724062832895,6724,561
   > Long-term Assets 
0
0
3,947
4,716
6,659
10,844
1,385,332
1,437,460
1,434,973
1,557,466
1,210,170
100,607
139,842
104,783
89,171
175,791
179,283
200,157
274,821
379,645
493,484
517,165
513,796
515,761
515,761513,796517,165493,484379,645274,821200,157179,283175,79189,171104,783139,842100,6071,210,1701,557,4661,434,9731,437,4601,385,33210,8446,6594,7163,94700
       Property Plant Equipment 
86,174
98,363
1,969
2,379
4,346
7,928
129,606
189,660
221,980
202,869
246,058
52,538
68,602
73,556
52,887
57,716
58,540
77,870
128,515
224,141
299,355
288,289
281,564
290,923
290,923281,564288,289299,355224,141128,51577,87058,54057,71652,88773,55668,60252,538246,058202,869221,980189,660129,6067,9284,3462,3791,96998,36386,174
       Goodwill 
0
15,405
1,619
1,507
1,178
849
880,369
881,217
881,217
960,817
538,582
0
0
0
0
75,217
79,176
80,789
93,084
93,084
102,960
102,960
102,960
95,221
95,221102,960102,960102,96093,08493,08480,78979,17675,2170000538,582960,817881,217881,217880,3698491,1781,5071,61915,4050
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,934
650
1,458
2,292
4,567
14,221
15,303
17,632
16,077
16,07717,63215,30314,2214,5672,2921,4586507,934000000000000000
       Intangible Assets 
99,851
90,913
86,282
1,507
1,178
233,489
346,112
328,617
294,479
351,326
328,972
15,030
14,597
14,237
22,553
23,044
22,362
21,905
32,287
32,430
135,367
128,707
128,050
118,243
118,243128,050128,707135,36732,43032,28721,90522,36223,04422,55314,23714,59715,030328,972351,326294,479328,617346,112233,4891,1781,50786,28290,91399,851
       Long-term Assets Other 
0
0
0
1,026
3,129
0
0
0
1,524
123
46,343
13,724
37,692
9,903
6,605
4,738
9,185
3,459
868
6,306
-102,960
-102,960
-102,960
-95,221
-95,221-102,960-102,960-102,9606,3068683,4599,1854,7386,6059,90337,69213,72446,3431231,5240003,1291,026000
> Total Liabilities 
291,293
358,397
45,638
49,463
53,825
64,844
691,679
724,152
866,249
1,003,532
859,092
720,079
398,876
445,365
366,340
482,662
554,997
580,295
792,980
869,574
752,689
705,002
786,653
723,843
723,843786,653705,002752,689869,574792,980580,295554,997482,662366,340445,365398,876720,079859,0921,003,532866,249724,152691,67964,84453,82549,46345,638358,397291,293
   > Total Current Liabilities 
285,130
336,418
40,316
44,142
46,560
53,649
525,758
333,198
348,001
668,080
761,595
710,156
391,361
443,898
364,358
478,320
549,076
574,607
784,507
663,315
575,951
523,657
457,614
477,357
477,357457,614523,657575,951663,315784,507574,607549,076478,320364,358443,898391,361710,156761,595668,080348,001333,198525,75853,64946,56044,14240,316336,418285,130
       Short-term Debt 
0
0
0
7
7,507
5,008
162,855
0
33,776
211,697
322,200
358,577
35,000
30,000
0
291
73,025
32,143
195,014
115,003
142,967
75,413
25,693
12,944
12,94425,69375,413142,967115,003195,01432,14373,025291030,00035,000358,577322,200211,69733,7760162,8555,0087,5077000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
291
11
32,143
195,014
115,003
135,022
66,379
15,375
3,681
3,68115,37566,379135,022115,003195,01432,14311291000000000000000
       Accounts payable 
234,099
288,771
186,026
211,068
217,175
240,760
304,174
297,324
269,227
373,083
353,876
251,284
311,554
375,775
327,491
373,883
406,657
475,285
526,511
492,804
359,988
365,469
352,273
406,012
406,012352,273365,469359,988492,804526,511475,285406,657373,883327,491375,775311,554251,284353,876373,083269,227297,324304,174240,760217,175211,068186,026288,771234,099
       Other Current Liabilities 
24,355
22,507
3,759
8,879
6,237
9,679
58,729
35,874
44,998
83,300
83,598
100,274
44,304
37,982
36,615
103,024
66,613
64,959
59,823
53,021
71,572
82,319
77,762
57,445
57,44577,76282,31971,57253,02159,82364,95966,613103,02436,61537,98244,304100,27483,59883,30044,99835,87458,7299,6796,2378,8793,75922,50724,355
   > Long-term Liabilities 
0
0
5,322
5,321
7,265
11,195
165,921
390,954
518,248
335,452
97,497
9,923
7,515
1,467
1,982
4,342
5,921
5,688
8,473
206,259
176,738
181,345
329,039
246,486
246,486329,039181,345176,738206,2598,4735,6885,9214,3421,9821,4677,5159,92397,497335,452518,248390,954165,92111,1957,2655,3215,32200
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,028
1,016
788
200,787
157,240
139,818
297,739
214,041
214,041297,739139,818157,240200,7877881,0161,0280000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
-7
-7,507
-5,008
-162,855
0
-33,776
-211,697
-322,200
-358,577
-35,000
-30,000
0
-291
-73,025
-32,143
-195,014
-115,003
-92,970
73,439
117,364
130,360
130,360117,36473,439-92,970-115,003-195,014-32,143-73,025-2910-30,000-35,000-358,577-322,200-211,697-33,7760-162,855-5,008-7,507-7000
> Total Stockholder Equity
254,509
250,644
10,817
14,727
27,265
34,108
1,269,167
1,344,456
1,200,653
1,197,932
1,066,954
832,919
682,527
610,806
578,829
573,002
552,152
536,763
513,108
513,254
475,954
513,672
487,188
475,918
475,918487,188513,672475,954513,254513,108536,763552,152573,002578,829610,806682,527832,9191,066,9541,197,9321,200,6531,344,4561,269,16734,10827,26514,72710,817250,644254,509
   Common Stock
216,190
216,139
3,501
3,676
3,677
3,678
1,200,257
1,204,722
1,074,470
1,083,578
1,367,566
1,367,647
1,365,258
1,337,226
1,294,414
1,255,466
1,238,394
1,226,904
1,200,755
1,207,794
1,286,194
1,286,144
1,286,144
1,286,144
1,286,1441,286,1441,286,1441,286,1941,207,7941,200,7551,226,9041,238,3941,255,4661,294,4141,337,2261,365,2581,367,6471,367,5661,083,5781,074,4701,204,7221,200,2573,6783,6773,6763,501216,139216,190
   Retained Earnings 
23,843
24,771
7,316
11,051
23,588
30,430
64,279
132,125
133,735
154,197
-303,740
-548,354
-698,766
-740,931
-733,122
-702,850
-696,890
-700,693
-701,919
-708,372
-753,803
-711,469
-741,134
-761,587
-761,587-741,134-711,469-753,803-708,372-701,919-700,693-696,890-702,850-733,122-740,931-698,766-548,354-303,740154,197133,735132,12564,27930,43023,58811,0517,31624,77123,843
   Capital Surplus 000000000000000000000000
   Treasury Stock0000-78,450-86,382-72,252-65,752-59,822-41,651-31,248-17,246000000000000
   Other Stockholders Equity 
0
0
2,459
0
0
0
0
0
0
0
0
0
0
0
17,537
20,386
226
10,552
14,272
13,832
-69,638
-66,231
-60,689
-51,682
-51,682-60,689-66,231-69,63813,83214,27210,55222620,38617,537000000000002,45900



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2023-01-31)

Gross Profit (+$)
totalRevenue3,660,240
Cost of Revenue-3,436,168
Gross Profit224,072224,072
 
Operating Income (+$)
Gross Profit224,072
Operating Expense-292,995
Operating Income-68,923-68,923
 
Operating Expense (+$)
Research Development0
Selling General Administrative82,616
Selling And Marketing Expenses210,379
Operating Expense292,995292,995
 
Net Interest Income (+$)
Interest Income597
Interest Expense-14,407
Other Finance Cost-0
Net Interest Income-13,810
 
Pretax Income (+$)
Operating Income-68,923
Net Interest Income-13,810
Other Non-Operating Income Expenses0
Income Before Tax (EBT)5,462-143,308
EBIT - interestExpense = -83,330
4,246
16,218
Interest Expense14,407
Earnings Before Interest and Taxes (EBIT)-68,92319,869
Earnings Before Interest and Taxes (EBITDA)-38,587
 
After tax Income (+$)
Income Before Tax5,462
Tax Provision-2,435
Net Income From Continuing Ops3,0273,027
Net Income1,811
Net Income Applicable To Common Shares1,811
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses3,729,163
Total Other Income/Expenses Net74,38513,810
 

Technical Analysis of Sigma Pharmaceuticals Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sigma Pharmaceuticals Ltd. The general trend of Sigma Pharmaceuticals Ltd is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sigma Pharmaceuticals Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Sigma Pharmaceuticals Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1.35.

The bearish price targets are: 1.285 > 1.09 > 1.0475.

Tweet this
Sigma Pharmaceuticals Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Sigma Pharmaceuticals Ltd. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Sigma Pharmaceuticals Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Sigma Pharmaceuticals Ltd. The current macd is 0.04543464.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sigma Pharmaceuticals Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Sigma Pharmaceuticals Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Sigma Pharmaceuticals Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Sigma Pharmaceuticals Ltd Daily Moving Average Convergence/Divergence (MACD) ChartSigma Pharmaceuticals Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Sigma Pharmaceuticals Ltd. The current adx is 63.22.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Sigma Pharmaceuticals Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Sigma Pharmaceuticals Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Sigma Pharmaceuticals Ltd. The current sar is 1.1975.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Sigma Pharmaceuticals Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Sigma Pharmaceuticals Ltd. The current rsi is 70.89. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -1/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
Sigma Pharmaceuticals Ltd Daily Relative Strength Index (RSI) ChartSigma Pharmaceuticals Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Sigma Pharmaceuticals Ltd. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sigma Pharmaceuticals Ltd price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Sigma Pharmaceuticals Ltd Daily Stochastic Oscillator ChartSigma Pharmaceuticals Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Sigma Pharmaceuticals Ltd. The current cci is 148.35.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Sigma Pharmaceuticals Ltd Daily Commodity Channel Index (CCI) ChartSigma Pharmaceuticals Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Sigma Pharmaceuticals Ltd. The current cmo is 43.95.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Sigma Pharmaceuticals Ltd Daily Chande Momentum Oscillator (CMO) ChartSigma Pharmaceuticals Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Sigma Pharmaceuticals Ltd. The current willr is -20.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Sigma Pharmaceuticals Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Sigma Pharmaceuticals Ltd Daily Williams %R ChartSigma Pharmaceuticals Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Sigma Pharmaceuticals Ltd.

Sigma Pharmaceuticals Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Sigma Pharmaceuticals Ltd. The current atr is 0.03900646.

Sigma Pharmaceuticals Ltd Daily Average True Range (ATR) ChartSigma Pharmaceuticals Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Sigma Pharmaceuticals Ltd. The current obv is 324,547,855.

Sigma Pharmaceuticals Ltd Daily On-Balance Volume (OBV) ChartSigma Pharmaceuticals Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Sigma Pharmaceuticals Ltd. The current mfi is 60.55.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Sigma Pharmaceuticals Ltd Daily Money Flow Index (MFI) ChartSigma Pharmaceuticals Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Sigma Pharmaceuticals Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-10BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-16MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-14MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-15ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.

6.3. Candlestick Patterns

Sigma Pharmaceuticals Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Sigma Pharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5070.893
Ma 20Greater thanMa 501.215
Ma 50Greater thanMa 1001.113
Ma 100Greater thanMa 2000.968
OpenGreater thanClose1.300
Total5/5 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Sigma Pharmaceuticals Ltd with someone you think should read this too:
  • Are you bullish or bearish on Sigma Pharmaceuticals Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Sigma Pharmaceuticals Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Sigma Pharmaceuticals Ltd

I send you an email if I find something interesting about Sigma Pharmaceuticals Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Sigma Pharmaceuticals Ltd.

Receive notifications about Sigma Pharmaceuticals Ltd in your mailbox!